Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same

Details for Australian Patent Application No. 2005289639 (hide)

Owner Aerovance, Inc.

Inventors Boisvert, David C.; Zaremba, Sydney M.; Longphre, Malinda; Wong, Teresa M.

Agent Freehills

Pub. Number AU-A-2005289639

PCT Pub. Number WO2006/036878

Priority 60/612,275 22.09.04 US; 11/026,396 29.12.04 US

Filing date 21 September 2005

Wipo publication date 6 April 2006

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/036878 Priority application(s): WO2006/036878

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289644-Imidazo{4,5-b}pyrazinone inhibitors of protein kinases

2005289638-Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof